303 related articles for article (PubMed ID: 10867409)
21. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
22. Recent position of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
Svoboda P; Kantorova I; Brhelova H; Vasickova J; Ochmann J
Hepatogastroenterology; 1997; 44(15):647-55. PubMed ID: 9222665
[TBL] [Abstract][Full Text] [Related]
23. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
[TBL] [Abstract][Full Text] [Related]
25. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
26. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
Papp M; Mezei G; Udvardy M; Altorjay I
Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
[TBL] [Abstract][Full Text] [Related]
27. [Histopathological investigation of the transjugular intrahepatic portocaval shunt (TIPS)].
Ziarkiewicz-Wróblewska B; Wróblewski T; Górnicka B; Michałowicz B; Rowiński O; Bogdańska M; Krawczyk M
Przegl Lek; 2001; 58(11):992-4. PubMed ID: 11987842
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
[TBL] [Abstract][Full Text] [Related]
29. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
[TBL] [Abstract][Full Text] [Related]
30. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
31. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
33. [Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].
Wu X; Li J; Cao J; Wu X; Ni X
Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):342-4. PubMed ID: 11825406
[TBL] [Abstract][Full Text] [Related]
34. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS).
Nolte W; Ehrenreich H; Wiltfang J; Pahl K; Unterberg K; Kamrowski-Kruck H; Schindler CG; Figulla HR; Buchwald AB; Hartmann H; Ramadori G
Liver; 2000 Feb; 20(1):60-5. PubMed ID: 10726962
[TBL] [Abstract][Full Text] [Related]
35. Systemic and regional changes in plasma endothelin following transient increase in portal pressure.
Kapoor D; Redhead DN; Hayes PC; Webb DJ; Jalan R
Liver Transpl; 2003 Jan; 9(1):32-9. PubMed ID: 12514771
[TBL] [Abstract][Full Text] [Related]
36. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunts: an update.
Rosado B; Kamath PS
Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of portal hypertension by portosystemic shunts].
Rössle M; Siegerstetter V; Huber M
Ther Umsch; 1998 Feb; 55(2):89-96. PubMed ID: 9545850
[TBL] [Abstract][Full Text] [Related]
39. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis.
Stanley AJ; Redhead DN; Bouchier IA; Hayes PC
Am J Gastroenterol; 1998 Dec; 93(12):2463-8. PubMed ID: 9860410
[TBL] [Abstract][Full Text] [Related]
40. [First experience with transjugular intrahepatic porto-systemic shunt (TIPS)].
Lázár I; Petó J; Kristóf T
Magy Seb; 2002 Feb; 55(1):9-15. PubMed ID: 11930565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
